| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of CELL SOURCE INC by Cell Source, Inc. (OTCPK:CLCS) through any online brokerage.
There are no as such competitors for CELL SOURCE INC by Cell Source, Inc..
There is no analysis for CELL SOURCE INC by Cell Source, Inc. to provide a consensus price target.
The stock price for CELL SOURCE INC by Cell Source, Inc. (OTCPK: CLCS) is $0.488332 last updated October 16, 2026 at 9:59 AM EDT.
There are no upcoming dividends for CELL SOURCE INC by Cell Source, Inc..
CELL SOURCE INC by Cell Source, Inc. does not have any upcoming earnings scheduled.
There is no upcoming split for CELL SOURCE INC by Cell Source, Inc..
CELL SOURCE INC by Cell Source, Inc. is in the Health Care sector and Biotechnology industry. They are listed on the OTCPK.
Cell Source Inc is a biotechnology company focused on developing cell therapy treatments focused on immunotherapy. The company is involved with the development of proprietary immune system management technology. The company's subsidiary...